Literature DB >> 20390223

Reduced ADAMTS13 in children with severe meningococcal sepsis is associated with severity and outcome.

Tamara N Bongers1, Marieke Emonts, Moniek P M de Maat, Ronald de Groot, Ton Lisman, Jan A Hazelzet, Frank W G Leebeek.   

Abstract

Multiple organ failure is a common feature of pediatric meningococcal sepsis and is associated with an imbalance of coagulation and fibrinolysis. This is partly due to an increased secretion of prothrombotic ultra-large von Willebrand factor (VWF) as the result of vascular endothelial damage. Another factor that may contribute is ADAMTS13, which converts VWF into smaller, less active, VWF multimers and thus influences VWF activity in plasma. We investigated the role of ADAMTS13 and VWF in the severity and outcome of sepsis. In 58 children with severe meningococcal sepsis we measured ADAMTS13 activity and antigen, VWF collagen binding activity (VWF:CB) and antigen levels (VWF:Ag), VWF propeptide and factor VIII at different time points during their stay in the paediatric intensive care unit. In the acute phase, both ADAMTS13 activity and antigen were decreased (median 23.4% and 33.7% of normal, respectively) and VWF:CB and VWF:Ag levels were strongly increased (325% and 348%, respectively.) ADAMTS13 antigen (23.9% vs. 34.6%; p=0.06) and VWF:CB (240% and 340% p<0.001) were lower in non-survivors than in survivors. ADAMTS13 activity and VWF:CB were both correlated with the severity of the disease, as indicated by the Pediatric Risk of Mortality score (R(s)= -0.38 and R(s)= -0.50, p=0.01, respectively, p<0.001). In the acute phase of severe sepsis decreased levels of ADAMTS13 and increased levels of VWF are observed, and the changes are related to severity of disease and outcome. This may contribute to the formation of microthrombi and the severity of thrombotic sequelae of sepsis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20390223     DOI: 10.1160/TH09-06-0376

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  15 in total

Review 1.  ADAMTS proteins in human disorders.

Authors:  Timothy J Mead; Suneel S Apte
Journal:  Matrix Biol       Date:  2018-06-06       Impact factor: 11.583

2.  Global Case-Fatality Rates in Pediatric Severe Sepsis and Septic Shock: A Systematic Review and Meta-analysis.

Authors:  Bobby Tan; Judith Ju-Ming Wong; Rehena Sultana; Janine Cynthia Jia Wen Koh; Mark Jit; Yee Hui Mok; Jan Hau Lee
Journal:  JAMA Pediatr       Date:  2019-04-01       Impact factor: 16.193

Review 3.  Rationale for Adjunctive Therapies for Pediatric Sepsis Induced Multiple Organ Failure.

Authors:  Bradley S Podd; Dennis W Simon; Santiago Lopez; Andrew Nowalk; Rajesh Aneja; Joseph A Carcillo
Journal:  Pediatr Clin North Am       Date:  2017-08-18       Impact factor: 3.278

4.  Three Hypothetical Inflammation Pathobiology Phenotypes and Pediatric Sepsis-Induced Multiple Organ Failure Outcome.

Authors:  Joseph A Carcillo; E Scott Halstead; Mark W Hall; Trung C Nguyen; Ron Reeder; Rajesh Aneja; Bita Shakoory; Dennis Simon
Journal:  Pediatr Crit Care Med       Date:  2017-06       Impact factor: 3.624

5.  Microangiopathic hemolytic anemia due to ADAMTS-13 loss in idiopathic systemic capillary leak syndrome.

Authors:  D C Moreira; C J Ng; R Quinones; X Liang; D W Chung; J Di Paola
Journal:  J Thromb Haemost       Date:  2016-10-24       Impact factor: 5.824

6.  A Multicenter Network Assessment of Three Inflammation Phenotypes in Pediatric Sepsis-Induced Multiple Organ Failure.

Authors:  Joseph A Carcillo; Robert A Berg; David Wessel; Murray Pollack; Kathleen Meert; Mark Hall; Christopher Newth; John C Lin; Allan Doctor; Tom Shanley; Tim Cornell; Rick E Harrison; Athena F Zuppa; Ron W Reeder; Russell Banks; John A Kellum; Richard Holubkov; Daniel A Notterman; J Michael Dean
Journal:  Pediatr Crit Care Med       Date:  2019-12       Impact factor: 3.624

7.  Do aspirin and other antiplatelet drugs reduce the mortality in critically ill patients?

Authors:  Wolfgang Lösche; Janina Boettel; Björn Kabisch; Johannes Winning; Ralf A Claus; Michael Bauer
Journal:  Thrombosis       Date:  2011-11-09

8.  Decreased ADAMTS 13 Activity is Associated With Disease Severity and Outcome in Pediatric Severe Sepsis.

Authors:  Jainn-Jim Lin; Oi-Wa Chan; Hsiang-Ju Hsiao; Yu Wang; Shao-Hsuan Hsia; Cheng-Hsun Chiu
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

Review 9.  VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP.

Authors:  Michael Schwameis; Christian Schörgenhofer; Alice Assinger; Margarete M Steiner; Bernd Jilma
Journal:  Thromb Haemost       Date:  2014-12-11       Impact factor: 5.249

10.  Von Willebrand factor, ADAMTS13 and mortality in dialysis patients.

Authors:  Gurbey Ocak; Mark Roest; Marianne C Verhaar; Maarten B Rookmaaker; Peter J Blankestijn; Willem Jan W Bos; Rob Fijnheer; Nathalie C Péquériaux; Friedo W Dekker
Journal:  BMC Nephrol       Date:  2021-06-16       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.